New partnership in Iberia

We are happy to announce a new partnership with DTA,S.L. in Iberia. Through the agreement, the Madrid-based company assumes responsibility for the distribution of MVision’s segmentation services in Spain and Portugal.

“We are very excited to work with MVision as their product fits perfectly to our mission of making the most innovative solutions to improve the quality of radiation therapy treatments available to our clients”, says Roberto Casado, the managing director and owner of DTA,S.L.. Mahmudul Hasan, the founder and CEO of MVision, is excited about the collaboration as well: “I am very happy to see DTA join our global partner network and look forward to making our products more available in the region.”

For more information, please contact pr@mvision.ai.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

2.7.2024

Breaking New Ground: MVision AI Contour+ for Upright MRI Scans

Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…

Articles

28.6.2024

AI Role in Improving Contouring Skills of Radiation Oncologists—Results From a Large International Project

Many regions of the globe face significant disparities between the need of radiation therapy and its availability [1]. Another challenge is providing adequate training for radiation oncology professionals [2]. The cancer burden is expected to rise everywhere, especially the low- and middle-income countries [3]. Artificial intelligence offers a wide range…

Articles

20.6.2024

World Kidney Cancer Day 2024: “Listen”

World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of shared decision making, patient’s empowerment to seek a second opinion and creating awareness around misinformation and how to check if sources are reliable (1). More…

News